Final Program
h6okmgq
h6okmgq
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
SUNDAY • MAY 15 39<br />
1006 Analysis of COPD Readmissions Pre and Post Initiation of a<br />
COPD Care Coordination Pathway/A. Chowdhury, M. Lee, M.<br />
Tan, A. Gupta, M. Kavuru, U. Vaid, Philadelphia, PA, p.A1109<br />
1007 Factors Associated with 30-Day Readmissions for COPD: A<br />
Health System Analysis/R.G. Buhr, A.D. Zider, I. Barjaktarevic,<br />
M.K. Ong, C.B. Cooper, Los Angeles, CA, p.A1112<br />
1008 Chronic Obstructive Pulmonary Disease Hospitalizations in<br />
2013-14: Demographic Trends in Readmission/R. Regalbuto,<br />
C.P. Aaron, N. Yip, M. Brinson, M. Daley, B. Regan, B.M.<br />
Thomashaw, New York, NY, p.A1113<br />
1009 Understanding Failures in Delivery of Care for COPD Patients<br />
with 30-Day Readmission; Exploring Process Improvement<br />
Opportunities/M.A. Zafar, E. Alessandrini, M.H. Eckman, E.J.<br />
Warm, R.J. Panos, Cincinnati, Ohio, p.A1114<br />
1010 The Impact of a COPD Care Coordination <strong>Program</strong> and Its<br />
Components on COPD 30-Day Readmission/A.N. Russo, G.<br />
Sathiyamoorthy, C. Lau, D. Uzunaslan, X. Wang, U. Hatipoglu,<br />
Cleveland, OH, p.A1115<br />
1011 Health Coaching and COPD Re-Hospitalization: A Randomized<br />
Study/R. Benzo, K. Vickers Douglas, P.J. Novotny, S. Tucker, J.<br />
Hoult, P. Neuenfeldt, J.E. Connett, K. Lorig, C. McEvoy, Rochester,<br />
MN, p.A1116<br />
1012 Predictors of Re-Admission After Hospitalization for Acute<br />
Exacerbation of COPD: Role of Glucocorticoid Dose and<br />
Duration/N. Csikesz, L. Nici, Providence, RI, p.A1117<br />
1013 An Integrated Practice Unit Model to Reduce 30-Day<br />
Readmission for COPD: Results from a Medicare Bundled<br />
Payments for Care Improvement Initiative/S.P. Bhatt, J.M. Wells,<br />
A.S. Iyer, D.P. Kirkpatrick, T.M. Parekh, E.M. Anderson, J.G.<br />
Sanders, J.K. Nichols, C.C. Blackburn, M.T. Dransfield,<br />
Birmingham, AL, p.A1118<br />
1014 Role of Long-Acting Bronchodilators and Inhaled<br />
Corticosteroids in 30 Days Readmission After Index<br />
Hospitalization for COPD/R. Bishwakarma, W. Zhang, Y.F. Kuo,<br />
G. Sharma, Galveston, TX, p.A1119<br />
1015 Distribution of Cardiac Comorbidities Across GOLD Grades<br />
and Their Association with Readmission Outcomes/R. Marron,<br />
S. Duffy, A. Kaur, N. Gaeckle, G. Criner, Philadelphia, PA, p.A1120<br />
1016 Comparative Effectiveness of Tiotropium Compared to No<br />
Long-Acting Bronchodilator After a Hospitalization for COPD/<br />
M.H. Roberts, D.W. Mapel, H. Petersen, Albuquerque, NM, p.A1121<br />
1017 Chronic Obstructive Pulmonary Disease (COPD)-Related<br />
Hospitalizations by Health Status Response Among Patients<br />
Receiving Arformoterol Tartrate or Placebo: Post Hoc Analyses<br />
from a 52-Week Randomized, Controlled Study/<br />
J. Donohue, V. Ganapathy, X. Zhou, L. Nelson, Chapel Hill, NC,<br />
p.A1122<br />
1018 Impact of Standardized Admission Order Template on COPD<br />
Exacerbation Admission Length of Stay and Readmission<br />
Rates/K. Leung, A. Zakaria, I. Turk, B. Greib, E. Tommolino, S.<br />
Patel, G. Chand, C. Jackson, A. Carter, W. Farra, Southfield, MI,<br />
p.A1123<br />
1019 Stratifying Risk and Personalizing Care: The Path Forward for<br />
Reducing COPD Readmissions in an Inner-City Safety Net<br />
Hospital/M. Islam, N. Ramesh, M. Harris, A. Chakravarti, J. Mecca,<br />
D. Steiger, P. Walker, New York, NY, p.A1124<br />
1020 Low Inspiratory Flow Rates Predict COPD and All Cause<br />
Readmissions/C.H. Loh, T.M. Lovings, J.A. Ohar, Winston Salem,<br />
NC, p.A1125<br />
1021 Trends of COPD Exacerbation Length of Stay, Disposition,<br />
Mortality and Total Charges 2009 - 2013- A Review of a National<br />
Database/M. Yaqoob, A. Alkhatib, J. Unterborn, Brighton, MA,<br />
p.A1126<br />
1022 COPD Is Associated with Significantly Higher Long-Term<br />
Readmission and Mortality but Has No Association with<br />
30-Day All-Cause or Heart Failure Readmission or All-Cause<br />
Mortality in Older Medicare Beneficiaries Hospitalized for Heart<br />
Failure/A.W. McLean, R. Khosla, P. Deedwania, A. Iyer, C.<br />
Inampudi, C. Morgan, S. Zhang, H. Sheriff, C. Faselis, R.D.<br />
Fletcher, G.C. Fonarow, W.S. Aronow, W.-C. Wu, C.J. Brown, S.D.<br />
Anker, R.M. Allman, A. Ahmed, Washington, DC, p.A1127<br />
1023 Characteristics and Comorbidities of Patients Readmitted to<br />
Yale-New Haven Hospital Following Index Admission for COPD<br />
Exacerbation/S. Farasat, C.L. Rochester, J.D. Possick, Derby, CT,<br />
p.A1128<br />
1024 A Pilot Study Evaluating Predictors of Thirty-Day Hospital<br />
Readmissions for COPD/V. Yap, A. Glucksman, D. Wilcox, R.<br />
ZuWallack, D. Datta, Farmington, CT, p.A1129<br />
1025 Chronic Obstructive Pulmonary Disease Risk Factors for<br />
Readmission in a Southern California Teaching Hospital/K.C. Fan,<br />
D. Dworsky, P. Averell, J. Waalen, D. Elias, La Jolla, CA, p.A1130<br />
A24<br />
POSTER DISCUSSION SESSION<br />
AUTOIMMUNE INTERSTITIAL LUNG DISEASE<br />
9:00 a.m. - 11:00 a.m. MOSCONE CENTER<br />
Room 133 (North Building, Lower Level)<br />
Poster Viewing 9:00-9:45<br />
Discussion 9:45-11:00<br />
Chairing: J. Dematte, MD, MBA, Chicago, IL<br />
R. Hallowell, MD, Boston, MA<br />
T. Moua, MD, Rochester, MN<br />
101 Increased Concentration of BAFF and APRIL in Patients with<br />
Autoimmune Pulmonary Alveolar Proteinosis/M. Hirose, A.<br />
Matsumuro, T. Arai, C. Sugimoto, M. Akira, Y. Inoue, Osaka,<br />
Japan, p.A1131<br />
102 Characterization of Patients Meeting Criteria for Interstitial<br />
Pneumonia with Autoimmune Features/J.M. Oldham, A.<br />
Adegunsoye, E. Valenzi, C.T. Lee, L.J. Witt, S. Hsu, L.W. Chen,<br />
J.H. Chung, S. Montner, A. Husain, V. Cottin, A. Fischer, I. Noth, R.<br />
Vij, M.E. Strek, Chicago, IL, p.A1132<br />
SUNDAY MORNING<br />
ATS 2016 • San Francisco
Change language